The consolidation wave rolls on

The UK's Competition and Markets Authority began reviewing Akzo Nobel's planned acquisition of Axalta Coating Systems, with a decision on further investigation due by Nov. 11. Shareholders approved the all-stock deal, pending regulatory approvals and expected to close by early 2027. The companies plan to file final voting results with the SEC.

AkzoNobel and Axalta Coating Systems said shareholders approved their merger, which will remove the AkzoNobel name and Amsterdam listing. A new name is not set. Regulatory clearance is still needed, with closing expected by year end or early next year. The combined firm will be Dutch-structured with dual HQs in Amsterdam and Philadelphia, led by AkzoNobel CEO Greg Poux-Guillaume. AkzoNobel shareholders get 55%, Axalta 45%, with projected €519m annual cost savings and nearly €15bn revenue.

AkzoNobel shareholders approved all resolutions at an EGM for the proposed all-share merger with Axalta Coating Systems, and Axalta shareholders also voted in favor. AkzoNobel said the deal can move to the next phase, pending regulatory approvals and other closing conditions. Completion is expected end-2026 or early-2027.

AkzoNobel shareholders approved all resolutions for the proposed all-share merger with Axalta at an Aug. 5, 2026 extraordinary general meeting, including merger approval, share issuance, board appointments and remuneration policy. Axalta shareholders also voted in favor. The deal moves to regulatory review and other closing conditions, with completion expected end-2026 or early 2027.

Axalta Coating Systems and Akzo Nobel said shareholders approved their all-stock merger of equals at meetings on 5 Aug 2026. Akzo Nobel approved merger-related resolutions including share issuance, board appointments and remuneration policy, while Axalta approved the deal at its special meeting. Completion still depends on regulatory approvals and customary closing conditions, expected late 2026 or early 2027.

Axalta Coating Systems shareholders approved an all-stock merger of equals with AkzoNobel, according to Axalta. AkzoNobel shareholders also voted to approve. Closing is still subject to regulatory approvals and other conditions, with expected completion in late 2026 to early 2027.